← Product Code [MWJ](/productcode/MWJ) · K982617

# TRACER (K982617)

_Heartland Medical Systems, Inc. · MWJ · Apr 9, 1999 · Cardiovascular · SESE_

**Canonical URL:** https://fda-staging.innolitics.com/device/K982617

## Device Facts

- **Applicant:** Heartland Medical Systems, Inc.
- **Product Code:** [MWJ](/productcode/MWJ.md)
- **Decision Date:** Apr 9, 1999
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.2800
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

## Indications for Use

PATIENTS WHO MAY BE EXPERIENCING CARDIAC EVENTS SYMPTOMATIC PULSE RATE ABNORMALITIES

## Device Story

Tracer device monitors patients experiencing cardiac events or symptomatic pulse rate abnormalities. Device captures cardiac signals; processes data to identify pulse rate irregularities; provides output for clinician review. Used in clinical settings or by patients under physician supervision. Output assists healthcare providers in diagnosing cardiac conditions and managing patient care. Benefits include timely detection of symptomatic cardiac events.

## Clinical Evidence

No clinical data provided in the document; substantial equivalence determination based on 510(k) regulatory review.

## Technological Characteristics

Cardiac monitoring device; intended for pulse rate abnormality detection. Technical specifications and materials not detailed in the provided text.

## Regulatory Identification

A medical magnetic tape recorder is a device used to record and play back signals from, for example, physiological amplifiers, signal conditioners, or computers.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with text around the perimeter. The central image is a stylized depiction of an eagle with three lines above it, representing the department's mission to promote health and well-being.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

ਰ 1999 APR

Mr. John A. Humphrey President Heartland Medical Systems, Inc. 725 Pickford Court Newbury Park, CA 91320

Re: K982617 Tracer Regulatory Class: II (two) Product Code: MJW Dated: February 15, 1999 March 4, 1999 Received:

Dear Mr. Humphrey:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any

{1}------------------------------------------------

Page 2 - Mr. Edward F. Waddell

obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, 2 Misbranding by reference to premarket notification? (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.qov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Thomas J. Callahan

Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

| Page |  |
|------|--|
| of   |  |

| 510(k) Number (if known): | k982617 |
|---------------------------|---------|
| Device Name:              | TRACER  |
| Indications For Use:      |         |

PATICATS WIS TARY BE EXCERIENCING For હર CARDIAC EVENTS SymfromMic Purse RATE ABACAITAL

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Division Sign Off

(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devic 510(k) Number

Over-The-Counter Use

Prescription Use (Per 21 CFR 801.109) OR

(Optional Format 1-2-96)

---

**Source:** [https://fda-staging.innolitics.com/device/K982617](https://fda-staging.innolitics.com/device/K982617)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com